Clinical Trials Logo

Clinical Trial Summary

A total of 60 female patients (30 patients in each group) with cutaneious warts diagnosed by a consultant dermatologist on physical examination were included in this study. In Group A patients were subjected to liquid nitrogen cryotherapy (-196 0C) while patients in Group B were subjected to vitamin D3 (5mg/ml) for 3 sessions at every 3 weeks interval. Effectiveness in both groups was ascertained in terms of > 50% reduction in wart size by an expert dermatologist on physical examination at the end of third session. Patients were followed for further 6 weeks after last session to look for any sort of recurrence and remission.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05739786
Study type Interventional
Source Combined Military Hospital Abbottabad
Contact
Status Completed
Phase Phase 1
Start date May 11, 2022
Completion date November 11, 2022

See also
  Status Clinical Trial Phase
Completed NCT02106260 - First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts Phase 1/Phase 2
Recruiting NCT00644579 - bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients Phase 2
Completed NCT03846648 - CyPep-1 in Cutaneous Warts Phase 1
Not yet recruiting NCT05902624 - Efficacy and Safety of Hepatitis B Virus Vaccine(HBV) in Treatment of Cutaneous Warts Early Phase 1
Completed NCT02333643 - A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. Phase 2
Completed NCT05023408 - Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts Phase 2
Completed NCT05862441 - A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts Phase 2/Phase 3
Completed NCT03734003 - Infrared Bioeffect System for the Treatment of Cutaneous Warts N/A